Johan Lombaard

3.7k total citations
14 papers, 423 citations indexed

About

Johan Lombaard is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Johan Lombaard has authored 14 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 8 papers in Virology and 5 papers in Epidemiology. Recurrent topics in Johan Lombaard's work include HIV/AIDS Research and Interventions (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (8 papers). Johan Lombaard is often cited by papers focused on HIV/AIDS Research and Interventions (10 papers), HIV/AIDS drug development and treatment (10 papers) and HIV Research and Treatment (8 papers). Johan Lombaard collaborates with scholars based in United States, Thailand and France. Johan Lombaard's co-authors include Lut Van Damme, Amy Corneli, Meng Wang, Kawango Agot, Khatija Ahmed, Angela D. M. Kashuba, Rachel Manongi, Jennifer Deese, Saidi Kapiga and Doug Taylor and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Johan Lombaard

13 papers receiving 416 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johan Lombaard United States 9 389 219 140 128 83 14 423
Freddie Kibengo Uganda 12 329 0.8× 199 0.9× 76 0.5× 100 0.8× 67 0.8× 24 418
Jonathan Wangisi Uganda 8 469 1.2× 340 1.6× 189 1.4× 108 0.8× 97 1.2× 10 505
Oluwakemi Sosanya United States 11 270 0.7× 195 0.9× 101 0.7× 68 0.5× 54 0.7× 14 317
Giulio Maria Corbelli United Kingdom 9 338 0.9× 224 1.0× 83 0.6× 97 0.8× 37 0.4× 24 390
Mary K. Irvine United States 12 411 1.1× 286 1.3× 198 1.4× 109 0.9× 46 0.6× 37 517
Monica M. F. Magnanini Brazil 8 513 1.3× 419 1.9× 93 0.7× 151 1.2× 89 1.1× 10 616
Jessica Schmitt United States 12 339 0.9× 212 1.0× 120 0.9× 41 0.3× 33 0.4× 37 444
Maggie Czarnogorski United States 11 288 0.7× 226 1.0× 93 0.7× 105 0.8× 38 0.5× 24 373
Alexander N. Thiong’o United Kingdom 13 304 0.8× 193 0.9× 115 0.8× 119 0.9× 57 0.7× 17 376
Shacara Johnson Lyons United States 6 450 1.2× 346 1.6× 187 1.3× 82 0.6× 64 0.8× 14 502

Countries citing papers authored by Johan Lombaard

Since Specialization
Citations

This map shows the geographic impact of Johan Lombaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Lombaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Lombaard more than expected).

Fields of papers citing papers by Johan Lombaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Lombaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Lombaard. The network helps show where Johan Lombaard may publish in the future.

Co-authorship network of co-authors of Johan Lombaard

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Lombaard. A scholar is included among the top collaborators of Johan Lombaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Lombaard. Johan Lombaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lombaard, Johan, Joseph Lutaakome, Rodica Van Solingen‐Ristea, et al.. (2025). Pharmacokinetics, Safety and Antiviral Activity of Rilpivirine in Antiretroviral-naïve Children With HIV ≥6 to <12 Years Old: Week 48 and Final Analysis of Cohort 2 From the Open-label, Phase 2 PAINT Study. The Pediatric Infectious Disease Journal. 44(7). 657–664.
2.
Lombaard, Johan, Francis Ssali, Thanyawee Puthanakit, et al.. (2021). Phase 2 Open-Label Study of Long-Term Safety, Tolerability, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive Adolescents Living with HIV-1. Antimicrobial Agents and Chemotherapy. 66(2). e0091621–e0091621. 2 indexed citations
3.
Murray, Miranda, Antonio Antela, Anthony Mills, et al.. (2020). Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks. AIDS and Behavior. 24(12). 3533–3544. 53 indexed citations
4.
Chounta, Vasiliki, Enrique Bernal, Johan Lombaard, et al.. (2020). 1035. Patient-Reported Outcomes on Long-Acting Cabotegravir + Rilpivirine as Maintenance Therapy: FLAIR 96-Week Results. Open Forum Infectious Diseases. 7(Supplement_1). S548–S548. 4 indexed citations
5.
Taylor, Doug, Amy Corneli, Angela D. M. Kashuba, et al.. (2020). FEM-PrEP: Adherence Patterns and Factors Associated With Adherence to a Daily Oral Study Product for Pre-exposure Prophylaxis. UNC Libraries. 13 indexed citations
6.
Orkin, Chloe, Jean‐Michel Molina, Johan Lombaard, et al.. (2019). Once-daily Doravirine in Human Immunodeficiency Virus Type 1–Infected, Antiretroviral-naive Adults: An Integrated Efficacy Analysis. Clinical Infectious Diseases. 70(7). 1344–1352. 8 indexed citations
7.
8.
Lombaard, Johan, Torsak Bunupuradah, Patricia M. Flynn, et al.. (2016). Rilpivirine as a Treatment for HIV-infected Antiretroviral-naïve Adolescents. The Pediatric Infectious Disease Journal. 35(11). 1215–1221. 7 indexed citations
9.
10.
Mandala, Justin, Kavita Nanda, Meng Wang, et al.. (2014). Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial. BMC Pharmacology and Toxicology. 15(1). 77–77. 17 indexed citations
11.
Agot, Kawango, Douglas Taylor, Amy Corneli, et al.. (2014). Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials. AIDS and Behavior. 19(5). 743–751. 65 indexed citations
12.
Corneli, Amy, Jennifer Deese, Meng Wang, et al.. (2014). FEM-PrEP. JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(3). 324–331. 134 indexed citations
13.
Corneli, Amy, Meng Wang, Kawango Agot, et al.. (2014). Perception of HIV Risk and Adherence to a Daily, Investigational Pill for HIV Prevention in FEM-PrEP. JAIDS Journal of Acquired Immune Deficiency Syndromes. 67(5). 555–563. 66 indexed citations
14.
Mack, Natasha, Kawango Agot, Khatija Ahmed, et al.. (2013). Implementing good participatory practice guidelines in the FEM-PrEP Preexposure Prophylaxis Trial for HIV Prevention among African Women: a focus on local stakeholder involvement. SHILAP Revista de lepidopterología. 127–127. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Freddie Kibengo Breakdown of academic impact, for papers by Jonathan Wangisi Breakdown of academic impact, for papers by Oluwakemi Sosanya Breakdown of academic impact, for papers by Giulio Maria Corbelli Breakdown of academic impact, for papers by Mary K. Irvine Breakdown of academic impact, for papers by Monica M. F. Magnanini Breakdown of academic impact, for papers by Jessica Schmitt Breakdown of academic impact, for papers by Maggie Czarnogorski Breakdown of academic impact, for papers by Alexander N. Thiong’o Breakdown of academic impact, for papers by Shacara Johnson Lyons
Rankless by CCL
2026